Patterns of Cervical Cytology Screening Outcomes among Premenopausal Women Attending University of Benin Teaching Hospital Benin-City, Nigeria

Authors

  • K. I. Odega Department of Anatomic Pathology, University of Benin Teaching Hospital, Benin City, Nigeria Author
  • G. D. Forae Department of Pathology, School of Medicine, University of Benin, Benin-City, Nigeria Author
  • E. E. Adeyemi Department of Anatomic Pathology, University of Benin Teaching Hospital, Benin City, Nigeria Author

Keywords:

screening, women, premenopausal, cytology, Cervix

Abstract

Background: This study is aimed at determining the patterns of cervical cytology screening outcomes among women of childbearing age attending tertiary health institution in Nigeria. 

Methods: This study reviewed the cytology register of over 1742 female patients aged 18 to 45 years attending various clinics in University of Benin Teaching Hospital from 1st January 2013 to 31st December 2016. During screening a sterile speculum was placed in the vagina and a rovers® cervex brush introduced through the vagina to the cervix. The central bristles of the rovers® cervex brush was inserted into the endo-cervical canal. Maintaining gentle pressure, it was rotated ve times in a clockwise direction. The rovers® cervex brush head was detached and placed in the preservative vial containing xative. This along with the request form was sent to the cytology laboratory. 

Result: A total of 1742 patients were screened for cervical lesions, the outcomes include 1342(77%) negative for intraepithelial lesion or malignancy (NILM), 231(13%) acute cervicitis, 55(3%) chronic cervicitis, 14(1%) atypical squamous cells of undetermined significance, 32(2%) low grade squamous intraepithelial lesion (LSIL) and 7(0.4%) high grade squamous intraepithelial lesion (HSIL).

Conclusions: Majority of the outcome of cervical cancer screening cases are actually negative for intraepithelial lesions or malignancy with significant number of cervicitis and premalignant lesions.

Downloads

Download data is not yet available.

Author Biography

  • G. D. Forae, Department of Pathology, School of Medicine, University of Benin, Benin-City, Nigeria

    Department of Anatomic Pathology, University of Benin Teaching Hospital, Benin City, Nigeria

References

1. Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, et al. Screening for cervical cancer: US Preventive Service Task Force Recommendation Statement. US Preventive Service Task Force. JAMA 2018, 320:674-86

2. Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas JO, Wabinga H. editors. Cancer in Africa: Epidemiology and Prevention. 2003; IARC Scientic Publications No. 153. Lyon: IARC Press.

3. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of worldwide mortality from 25 cancers in 1990. Inter J Cancer. 1999; 83: 18 – 29

4. Parkin S, Brennan P, and Boffetta P. Meta analysis of social Inequality and the risk of cervical cancer. Inter J Cancer 1990; 105: 687-91.

5. Obaseki DE, Forae GD, Okobia M, Ibadin MO. Cancer trends in Benin-City, Nigeria: A six-year report of the Benin cancer registry-A population based analysis (2009-2014). The Benin cancer registry (BCR) report 2015; 1(1):1-60 6. Miller AB, Chamberlain J, Day NE, Hakama M, Prorok PC. Cambridge University Press. 2002; 184 –98.

7. Konje JC, Ogunniyi JO, Otolorin EO, Odusoga OL, Ogunlusi MO. Cervical cancer screening at Ibadan. Eur J Gynaecol Oncol.1991; 12(1): 55-61.

8. Anorlu R, Goodman A, Goldie SJ. HPV Communication: Review of existing research and recommendations for patient education. CA Cancer J Clin. 2003; 54:245-7.

9. Ferlay J, Shin HR, Bray F, Forman D, Mathew C, Perkin, DM. Estimates of worldwide burden on cancer in 2008.GLOBOCAN. Inter J C. 2008; 127(12) 2893-917.

10. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Inter J Cancer, 1999; 80: 827-41.

11. Symonds RP. Screening for cervical cancer: different problems in the developing and the developed world. Eur J cancer care 1997; 6(4): 272-9.

12. Sirovich BE. Cervical cancer screening among women without a cervix. JAMA 2004; 291 (2): 2990-3.

13. Miller AB, Nazeer S, Fonn S, Brandup- Lukanow A, Retiman R. Report on consensus conference on cervical cancer screening and management. Inter J Cancer 2000; 86 (3): 440-7.

14. Kobelin MH, Kobelin CG, Burke L, Lavin P, Niloff JM, Kim YB. Incidence and predictors of cervical dysplasia in patients with minimally abnormal Papanicolaou smears. Obstet Gynecol 1998; 92:356-9.

15. Makuza Jean damascene. Prevalence and risk factors for cervical cancer and precancerous lesions in Rwanda: The Pan Afr Med J 2015;22:26-30

16. Daniel CN, Emmanuel IN, Lydia RA, Magaji A, Siddique MS. Screening for cervical cancer: Experience from a university hospital in north western Nigeria. J Basic Clin Reprod Sci 2013; 2:18-21.

Downloads

Published

2020-08-02

Issue

Section

Original Articles

How to Cite

Odega, K. I., Forae, G. D., & Adeyemi, E. E. (2020). Patterns of Cervical Cytology Screening Outcomes among Premenopausal Women Attending University of Benin Teaching Hospital Benin-City, Nigeria. Niger Delta Journal of Medical Sciences (NDJMS), 2(3), 56-62. https://ndjms.ndu.edu.ng/index.php/home/article/view/30